Abstract:In preclinical models of multiple sclerosis, systemic inflammation has an impact on the compartmentalized inflammatory process within the central nervous system and results in axonal loss. It remains to be shown whether this is the case in humans, specifically whether systemic inflammation contributes to spinal cord or brain atrophy in multiple sclerosis. Hence, an observational longitudinal study was conducted to delineate the relationship between systemic inflammation and atrophy using magnetic resonance imaging: the SIMS (Systemic Inflammation in Multiple Sclerosis) study. Systemic inflammation and progression were assessed in people with progressive multiple sclerosis (n = 50) over two and a half years. Eligibility criteria included: (i) primary or secondary progressive multiple sclerosis; (ii) age ≤ 70; and (iii) Expanded Disability Status Scale ≤ 6.5. First morning urine was collected weekly to quantify systemic inflammation by measuring the urinary neopterin-to-creatinine ratio using a validated ultra-performance liquid chromatography mass spectrometry technique. The urinary neopterin-to-creatinine ratio temporal profile was characterized by short-term responses overlaid on a background level of inflammation, so these two distinct processes were considered as separate variables: background inflammation and inflammatory response. Participants underwent MRI at the start and end of the study, to measure cervical spinal cord and brain atrophy. Brain and cervical cord atrophy occurred on the study, but the most striking change was seen in the cervical spinal cord, in keeping with the corticospinal tract involvement that is typical of progressive disease. Systemic inflammation predicted cervical cord atrophy. An association with brain atrophy was not observed in this cohort. A time lag between systemic inflammation and cord atrophy was evident, suggesting but not proving causation. The association of the inflammatory response with cord atrophy depended on the level of background inflammation, in keeping with experimental data in preclinical models where the effects of a systemic inflammatory challenge on tissue injury depended on prior exposure to inflammation. A higher inflammatory response was associated with accelerated cord atrophy in the presence of background systemic inflammation below the median for the study population. Higher background inflammation, while associated with cervical cord atrophy itself, subdued the association of the inflammatory response with cord atrophy. Findings were robust to sensitivity analyses adjusting for potential confounders and excluding cases with new lesion formation. In conclusion, systemic inflammation associates with, and precedes, multiple sclerosis progression. Further work is needed to prove causation since targeting systemic inflammation may offer novel treatment strategies for slowing neurodegeneration in multiple sclerosis.

Systemic Inflammation and the Risk of Multiple System Atrophy: A Prospective Cohort Study

Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross-Sectional Study

Temporal Changes in Brain Morphology Related to Inflammation and Schizophrenia: an Omnigenic Mendelian Randomization Study.

Association of TNF-α Rs1799964 and IL-1β Rs16944 Polymorphisms with Multiple System Atrophy in Chinese Han Population.

Prevalence Of And Factors Associated With Cognitive Impairment In Multiple System Atrophy With Different Disease Durations

Vascular Risk Factors and Cognition in Multiple System Atrophy

Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis

Identification of crucial inflammaging related risk factors in multiple sclerosis

Fatigue in Patients With Multiple System Atrophy A Prospective Cohort Study

Multidimensional Biomarkers for Multiple System Atrophy: an Update and Future Directions

Predicting the Prognosis of Multiple System Atrophy Using Cluster and Principal Component Analysis.

Diagnostic value and correlation analysis of serum cytokine levels in patients with multiple system atrophy

Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study

Longitudinal Evolution of Motor and Non-Motor Symptoms in Early-Stage Multiple System Atrophy: a 2-Year Prospective Cohort Study

Identifying New Subtypes of Multiple System Atrophy Using Cluster Analysis

Age at Menarche and Risk of Multiple Sclerosis: Current Progress From Epidemiological Investigations

Functional Variant Rs3135500 in NOD2 Increases the Risk of Multiple System Atrophy in a Chinese Population

The genetic basis of multiple system atrophy

Contra-Directional Expression of Serum Homocysteine and Uric Acid As Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study

Alterations of the Gut Microbiota in Multiple System Atrophy Patients

Autonomic Dysfunction and Motor Progression in Multiple System Atrophy: A 1-Year Prospective Cohort Study